RecallDepth
Class III Terminated

Fenofibric Acid, immediate release tablet, 105 mg, a) 30 count bottle (NDC 53489-678-07), b) 90 count bottle (NDC 53489-678-90), Rx only, Mutual Pharmaceutical Co., Inc., Philadelphia, PA 19124 USA

This recall has been terminated (originally issued January 15, 2014).

Company
Mutual Pharmaceutical Company, Inc.
Recall Initiated
February 27, 2013
Posted
January 15, 2014
Recall Number
D-400-2014
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Philadelphia, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice. Specifically, the labeling should read "If a severely depressed HDL-C level is detected, fibrate therapy should be withdrawn, and the HDL-C level monitored until it has returned to baseline, and fibrate therapy should not be re-initiated." The labeling for the recalled lots

Distribution

Nationwide and Puerto Rico.

Lot / Code Info

lot 6581105 & 6581106 exp. 07/15, and lot 6623001 & 6623002 exp. 01/16

More recalls by Mutual Pharmaceutical Company, Inc.

View all recalls by this company →

Other recent Class III Drug recalls